• However, in patients with FAP who have had colectomy with ileoanal anastomosis, sulindac or celecoxib may be beneficial in reducing the size and the number of adenomatous polyps in the remaining rectum. (medscape.com)
  • 2. Outcomes for patients undergoing continent ileostomy after a failed ileal pouch-anal anastomosis. (nih.gov)
  • 4. Durability of ileal pouch-anal anastomosis and continent ileostomy. (nih.gov)
  • 7. What are the outcomes of reoperative restorative proctocolectomy and ileal pouch-anal anastomosis surgery? (nih.gov)
  • 9. Modified two-stage ileal pouch-anal anastomosis: equivalent outcomes with less resource utilization. (nih.gov)
  • 12. Crohn's disease and indeterminate colitis and the ileal pouch-anal anastomosis: outcomes and patterns of failure. (nih.gov)
  • 16. Is an ileal pouch an alternative for patients requiring surgery for Crohn's proctocolitis? (nih.gov)
  • 17. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. (nih.gov)
  • Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis. (nih.gov)
  • Sigmoidoscopic surveillance and ablation of any polyps in the retained rectum or ileal pouch should be performed every 3-6 months in patients with FAP who have undergone colonic (total or subtotal) resection. (medscape.com)
  • There is an increased risk for adenomas and carcinomas in the ileal pouch, as there is increased epithelial cell proliferation at this site as compared to the afferent ileal loop. (medscape.com)
  • Cancers of the rectum (in patients who have had subtotal colectomy with ileorectal anastomosis) have been reported despite treatment with sulindac and celecoxib therapy. (medscape.com)
  • Capsule endoscopy is useful for the surveillance of jejunal-ileal polyps in selected patients but is not recommended for duodenal or ampullary surveillance. (medscape.com)